These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29348848)

  • 21. Association Between PD-L1 and HPV Status and the Prognostic Value of PD-L1 in Oropharyngeal Squamous Cell Carcinoma.
    Kim HS; Lee JY; Lim SH; Park K; Sun JM; Ko YH; Baek CH; Son YI; Jeong HS; Ahn YC; Lee MY; Hong M; Ahn MJ
    Cancer Res Treat; 2016 Apr; 48(2):527-36. PubMed ID: 26511814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significant association of increased PD-L1 and PD-1 expression with nodal metastasis and a poor prognosis in oral squamous cell carcinoma.
    Maruse Y; Kawano S; Jinno T; Matsubara R; Goto Y; Kaneko N; Sakamoto T; Hashiguchi Y; Moriyama M; Toyoshima T; Kitamura R; Tanaka H; Oobu K; Kiyoshima T; Nakamura S
    Int J Oral Maxillofac Surg; 2018 Jul; 47(7):836-845. PubMed ID: 29395669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of PD-L1 and ZEB-1 expression patterns with clinicopathological characteristics and prognosis in oral squamous cell carcinoma.
    Takamaru N; Fukuda N; Akita K; Kudoh K; Miyamoto Y
    Oncol Lett; 2022 Mar; 23(3):75. PubMed ID: 35111244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cisplatin-induced programmed cell death ligand-2 expression is associated with metastasis ability in oral squamous cell carcinoma.
    Sudo S; Kajiya H; Okano S; Sasaki M; Katsumata Y; Ohno J; Ikebe T; Hiraki A; Okabe K
    Cancer Sci; 2020 Apr; 111(4):1113-1123. PubMed ID: 32012401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PD-L1 Expression Correlated with Clinicopathological Factors and Akt/Stat3 Pathway in Oral SCC.
    Geum DH; Hwang DS; Lee CH; Cho SD; Jang MA; Ryu MH; Kim UK
    Life (Basel); 2022 Feb; 12(2):. PubMed ID: 35207525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between the expressions of PD-L1 and tumor-infiltrating lymphocytes in oral squamous cell carcinoma.
    Cho YA; Yoon HJ; Lee JI; Hong SP; Hong SD
    Oral Oncol; 2011 Dec; 47(12):1148-53. PubMed ID: 21911310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Galectin 3 expression in primary oral squamous cell carcinomas.
    Weber M; Büttner-Herold M; Distel L; Ries J; Moebius P; Preidl R; Geppert CI; Neukam FW; Wehrhan F
    BMC Cancer; 2017 Dec; 17(1):906. PubMed ID: 29284429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Development of programmed death receptor-1 and programmed death receptor-1 ligand in oral squamous cell carcinoma].
    Chen ZH; Wu YD
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2020 Aug; 38(4):449-453. PubMed ID: 32865367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic contrast-enhanced MRI as a predictor of programmed death ligand-1 expression in patients with oral squamous cell carcinoma.
    Tekiki N; Fujita M; Okui T; Kawai H; Oo MW; Kawazu T; Hisatomi M; Okada S; Takeshita Y; Barham M; Nagatsuka H; Yanagi Y; Asaumi JI
    Oncol Lett; 2021 Nov; 22(5):778. PubMed ID: 34594419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of immune checkpoint protein in oral squamous cell carcinoma and its clinicopathological correlation: A tertiary care center cross-sectional study.
    Ratnakar S; Kumar M; Maurya MK; Qayoom S; Sagar M; Babu S; Kumar V
    J Oral Maxillofac Pathol; 2023; 27(3):597. PubMed ID: 38033955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beyond PD-L1-Identification of Further Potential Therapeutic Targets in Oral Cancer.
    Weber M; Lutz R; Olmos M; Glajzer J; Baran C; Nobis CP; Möst T; Eckstein M; Kesting M; Ries J
    Cancers (Basel); 2022 Apr; 14(7):. PubMed ID: 35406584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of PD-L1 is HPV/P16-independent in oral squamous cell carcinoma.
    Kitichotkul K; Lertprasertsuke N; Kintarak S; Pongsiriwet S; Powcharoen W; Iamaroon A
    Heliyon; 2022 Oct; 8(10):e10667. PubMed ID: 36212017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral squamous cell carcinoma suppressed antitumor immunity through induction of PD-L1 expression on tumor-associated macrophages.
    Jiang C; Yuan F; Wang J; Wu L
    Immunobiology; 2017 Apr; 222(4):651-657. PubMed ID: 28017495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and Biological Significance of PD-L1 Expression Within the Tumor Microenvironment of Oral Squamous Cell Carcinoma.
    Takahashi H; Sakakura K; Arisaka Y; Tokue A; Kaira K; Tada H; Higuchi T; Okamoto A; Tsushima Y; Chikamatsu K
    Anticancer Res; 2019 Jun; 39(6):3039-3046. PubMed ID: 31177146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral squamous cell carcinoma cell-derived GM-CSF regulates PD-L1 expression in tumor-associated macrophages through the JAK2/STAT3 signaling pathway.
    Wang P; Tao L; Yu Y; Wang Q; Ye P; Sun Y; Zhou J
    Am J Cancer Res; 2023; 13(2):589-601. PubMed ID: 36895967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crosstalk between PD-L1 and Jak2-Stat3/ MAPK-AP1 signaling promotes oral cancer progression, invasion and therapy resistance.
    Jha A; Alam M; Kashyap T; Nath N; Kumari A; Pramanik KK; Nagini S; Mishra R
    Int Immunopharmacol; 2023 Nov; 124(Pt A):110894. PubMed ID: 37678027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased malignancy of oral squamous cell carcinomas (oscc) is associated with macrophage polarization in regional lymph nodes - an immunohistochemical study.
    Wehrhan F; Büttner-Herold M; Hyckel P; Moebius P; Preidl R; Distel L; Ries J; Amann K; Schmitt C; Neukam FW; Weber M
    BMC Cancer; 2014 Jul; 14():522. PubMed ID: 25042135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Programmed cell death-ligand 1 expression in oral squamous cell carcinoma is associated with an inflammatory phenotype.
    Satgunaseelan L; Gupta R; Madore J; Chia N; Lum T; Palme CE; Boyer M; Scolyer RA; Clark JR
    Pathology; 2016 Oct; 48(6):574-80. PubMed ID: 27590194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacterial Lipopolysaccharide Induces PD-L1 Expression and an Invasive Phenotype of Oral Squamous Cell Carcinoma Cells.
    Omori Y; Noguchi K; Kitamura M; Makihara Y; Omae T; Hanawa S; Yoshikawa K; Takaoka K; Kishimoto H
    Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does surgery affect systemic immune response? a perioperative analysis of TGF-β, IL-8 and CD45RO.
    Trumet L; Ries J; Ivenz N; Sobl P; Wehrhan F; Lutz R; Kesting M; Weber M
    Front Oncol; 2023; 13():1307956. PubMed ID: 38162490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.